Network / Interactive Map / Entity profile
PRECIGEN
SME
PRECIGEN
Description
Precigen develops next generation of gene and cell therapies designed for targeting the most urgent and intractable diseases in our core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases.
Resources
PRECIGEN
Address
20358 SENECA MEADOWS PKWY, GERMANTOWN MARYLAND 20876 UNITED STATES
United States
United States
Contact
info@actobio.com
Description
Precigen develops next generation of gene and cell therapies designed for targeting the most urgent and intractable diseases in our core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases.
Resources
Matchmaking
Connect with PRECIGEN
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways
TRL
Not yet on COBIOE directory?
Want to access to more data?
Want to contact this entity?